Connect with us

Healthcare Buzz

Alembic Pharma Q3 Profit Up 30 Percent To Rs 170 Crore

Alembic Pharmaceuticals has reported 30 percent rise in consolidated net profit to Rs 169.83 crore for the quarter ended December 31, 2018 mainly on account of robust sales in the US. The company had posted a net profit of Rs 130.60 crore in the year-ago period. Consolidated revenue from operations stood at Rs 1018.15 crore in the reported quarter as against Rs 840.02 crore in December quarter 2017. The growth in the quarter was attributed to a strong performance in the US and international business. The company’s formulation as well as active pharmaceutical ingredient (API) facilities was successfully approved by USFDA during the quarter. The US business grew 42 percent to Rs 308 crore for the December quarter 2018 as against Rs 218 crore in the year-ago period.

Copyright © 2024 Medical Buyer

error: Content is protected !!